These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18516010)

  • 1. [Role of prostaglandins in colon cancer].
    Myung SJ; Kim IH
    Korean J Gastroenterol; 2008 May; 51(5):274-9. PubMed ID: 18516010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
    Tai HH; Chi X; Tong M
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 in colon carcinogenesis.
    Sasaki Y; Nakatani Y; Hara S
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):42-5. PubMed ID: 26150361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
    Chell S; Kaidi A; Williams AC; Paraskeva C
    Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention.
    Earnest DL; Hixson LJ; Alberts DS
    J Cell Biochem Suppl; 1992; 16I():156-66. PubMed ID: 1305681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and cancer.
    Wang D; Dubois RN
    Gut; 2006 Jan; 55(1):115-22. PubMed ID: 16118353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
    Cho H; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):461-5. PubMed ID: 12468268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin, a cox inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation.
    Frenkian M; Segond N; Pidoux E; Cohen R; Jullienne A
    Prostaglandins Other Lipid Mediat; 2001 May; 65(1):11-20. PubMed ID: 11352223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
    Moreno J; Krishnan AV; Peehl DM; Feldman D
    Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
    Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
    Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
    Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
    Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.
    Quidville V; Segond N; Lausson S; Frenkian M; Cohen R; Jullienne A
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):14-30. PubMed ID: 16997128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
    Krishnan AV; Feldman D
    Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin catabolic enzymes as tumor suppressors.
    Tai HH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 and colon cancer: potential targets for chemoprevention.
    Fournier DB; Gordon GB
    J Cell Biochem Suppl; 2000; 34():97-102. PubMed ID: 10762021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COX-2 inhibitor and colon cancer].
    Tsujii M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1799-805. PubMed ID: 11729471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.